NewsLinks.net

Your trusted source for the latest news

Competition, not price controls, just slashed GLP-1 prices

Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay as little as $349 for a monthly dose of these medicines. The company has also d......

Source: Washington Examiner

Original URL: https://www.washingtonexaminer.com/restoring-america/faith-freedom-self-reliance/3901966/competition-not-price-controls-slashed-glp-1-prices/